MBIP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.899800E-01
Normal-vs-Stage2
6.474200E-01
Normal-vs-Stage3
4.608000E-01
Normal-vs-Stage4
1.834360E-01
Stage1-vs-Stage2
5.446800E-01
Stage1-vs-Stage3
1.558220E-01
Stage1-vs-Stage4
2.226200E-01
Stage2-vs-Stage3
3.893400E-01
Stage2-vs-Stage4
1.849510E-02
Stage3-vs-Stage4
1.519220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.291600E-01
Normal-vs-AfricanAmerican
6.702400E-01
Normal-vs-Asian
8.267200E-01
Caucasian-vs-AfricanAmerican
8.731200E-01
Caucasian-vs-Asian
5.924000E-01
AfricanAmerican-vs-Asian
8.167000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.351200E-01
Normal-vs-Female
6.203400E-01
Male-vs-Female
6.388400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.671200E-01
Normal-vs-Age(41-60Yrs)
3.124800E-01
Normal-vs-Age(61-80Yrs)
8.007400E-01
Normal-vs-Age(81-100Yrs)
7.752400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.495800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.608200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.897980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.301100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.044100E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.490160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.121200E-01
Normal-vs-Daily Drinker
5.302000E-01
Normal-vs-Weekly Drinker
7.146000E-01
Normal-vs-Occasional Drinker
3.435000E-01
Normal-vs-Social Drinker
6.717800E-01
Non Drinker-vs-Daily Drinker
8.773600E-02
Non Drinker-vs-Weekly Drinker
6.680800E-01
Non Drinker-vs-Occasional Drinker
2.544500E-02
Non Drinker-vs-Social Drinker
3.490600E-01
Daily Drinker-vs-Weekly Drinker
6.085700E-02
Daily Drinker-vs-Occasional Drinker
6.294800E-01
Daily Drinker-vs-Social Drinker
2.428400E-01
Weekly Drinker-vs-Occasional Drinker
1.724380E-02
Weekly Drinker-vs-Social Drinker
2.044600E-01
Occasional Drinker-vs-Social Drinker
8.244200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.682980E-01
Normal-vs-Grade 2
1.777240E-01
Normal-vs-Grade 3
1.395840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.228180E-01
Grade 1-vs-Grade 3
3.387800E-01
Grade 1-vs-Grade 4
1.682980E-01
Grade 2-vs-Grade 3
6.304800E-01
Grade 2-vs-Grade 4
1.777240E-01
Grade 3-vs-Grade 4
1.395840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.433600E-01
Normal-vs-NonDiabetic
6.095000E-01
Diabetic-vs-NonDiabetic
1.752020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.900400E-01
Normal-vs-NoPancreatitis
6.608400E-01
Pancreatitis-vs-NoPancreatitis
9.882000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.717000E-01
Normal-vs-N1
6.052200E-01
N0-vs-N1
1.551440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.479600E-03
Normal-vs-TP53-NonMutant
7.247400E-01
TP53-Mutant-vs-TP53-NonMutant
4.577400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
